| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | benzodiazepine receptor binding | 1.88e-08 | 5 | 158 | 4 | GO:0030156 | |
| GeneOntologyMolecularFunction | chromatin binding | SOX10 TSHZ3 PCGF2 KLF14 CHD3 ACSS2 BAHD1 ZNF750 SALL1 BRCA1 PRKCB ASXL2 USP3 PHF10 CRAMP1 CBX2 BAHCC1 | 8.04e-05 | 739 | 158 | 17 | GO:0003682 |
| GeneOntologyBiologicalProcess | neuromuscular synaptic transmission | 7.70e-06 | 36 | 158 | 5 | GO:0007274 | |
| Domain | FN3_dom | IL12RB2 LRIT2 FLNC DSCAM TSPOAP1 FNDC3A VWA1 RIMBP3 RIMBP3C RIMBP3B | 9.40e-06 | 209 | 154 | 10 | IPR003961 |
| Domain | FN3 | IL12RB2 LRIT2 FLNC DSCAM TSPOAP1 FNDC3A VWA1 RIMBP3C RIMBP3B | 2.33e-05 | 185 | 154 | 9 | SM00060 |
| Domain | FN3 | IL12RB2 LRIT2 DSCAM TSPOAP1 FNDC3A VWA1 RIMBP3 RIMBP3C RIMBP3B | 4.13e-05 | 199 | 154 | 9 | PS50853 |
| Domain | SH3_2 | 7.78e-05 | 86 | 154 | 6 | PF07653 | |
| Domain | SH3_2 | 7.78e-05 | 86 | 154 | 6 | IPR011511 | |
| Domain | TACC | 2.02e-04 | 3 | 154 | 2 | PF05010 | |
| Domain | TACC | 2.02e-04 | 3 | 154 | 2 | IPR007707 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | SEMA4F FLNC HIP1 MYO9B MEX3D INTS1 ADGRB2 LAMB3 GTF2IRD1 POM121C BAHD1 C2CD2 CASZ1 C6orf132 PPP1R26 HIVEP3 GAS2L1 C2CD3 PWWP2B CDK13 BTBD7 RPTOR DISP2 RIPOR1 CACNA1H DNMBP CRAMP1 WNK2 PRRC2B IQCE CBX2 BAHCC1 | 8.61e-17 | 1105 | 161 | 32 | 35748872 |
| Pubmed | Interaction network of human early embryonic transcription factors. | TSHZ3 TCF20 SCAND1 ZNF217 ZHX2 POM121C PRDM2 ZNF512B BPTF SALL1 ZNF608 ASXL2 PHF10 ZMYM3 PRRC2B BAHCC1 | 9.89e-12 | 351 | 161 | 16 | 38297188 |
| Pubmed | TCF20 TSPOAP1 STXBP5 ZHX2 SNX19 ARFGEF3 BTBD7 MAST1 DISP2 RIPOR1 CACNA1H ASXL2 SRRM2 ZMYM3 PRRC2B | 8.57e-10 | 407 | 161 | 15 | 12693553 | |
| Pubmed | Structure and evolution of RIM-BP genes: identification of a novel family member. | 2.20e-09 | 5 | 161 | 4 | 17855024 | |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | PPFIBP2 AFF3 RTN3 FAM117B CHD3 VPS54 GTF2IRD1 ZHX2 SHROOM2 C2CD2 CASZ1 ARFGEF3 HIVEP3 BPTF PWWP2B ZNF608 CDK13 RPTOR MAST1 RIPOR1 CACNA1H USP3 CRAMP1 WNK2 | 1.04e-07 | 1489 | 161 | 24 | 28611215 |
| Pubmed | SEMA4F TCF20 SHROOM2 NACAD CASZ1 MAST1 SRRM2 CRAMP1 WNK2 IQCE | 1.51e-07 | 233 | 161 | 10 | 37704626 | |
| Pubmed | SASH1 SMPD4 FNDC3A NACAD BAHD1 ZNF512B STOX2 ZNF608 RPTOR DNMBP CRAMP1 WNK2 IQCE PPP6R3 | 1.96e-07 | 529 | 161 | 14 | 14621295 | |
| Pubmed | RIM-BP3 is a manchette-associated protein essential for spermiogenesis. | 3.88e-07 | 4 | 161 | 3 | 19091768 | |
| Pubmed | Integrative characterization of germ cell-specific genes from mouse spermatocyte UniGene library. | 4.27e-07 | 14 | 161 | 4 | 17662146 | |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | TCF20 CHD3 ZNF217 GTF2IRD1 PRDM2 BPTF PWWP2B CDK13 RPTOR RIPOR1 TACC3 DNMBP SRRM2 PHF10 ZMYM3 PPP6R3 | 7.01e-07 | 774 | 161 | 16 | 15302935 |
| Pubmed | SOX10 TSHZ3 TCF20 CHD3 ZNF217 ZHX2 POM121C PRDM2 ZNF512B BPTF SALL1 BRCA1 ZNF608 DCP1B DGKK ASXL2 SRRM2 PHF10 ZMYM3 PRRC2B PPP6R3 CBX2 | 8.07e-07 | 1429 | 161 | 22 | 35140242 | |
| Pubmed | 9.67e-07 | 5 | 161 | 3 | 16807365 | ||
| Pubmed | High-resolution photocatalytic mapping of SARS-CoV-2 spike interactions on the cell surface. | AMPD2 FAM117B ZNF217 HMMR GTF2IRD1 C6orf132 DMRT3 CCDC120 TACC3 PRRC2B | 1.86e-06 | 307 | 161 | 10 | 37499664 |
| Pubmed | Identification and functional characterization of transcriptional activators in human cells. | JCAD AMPD2 TSHZ3 TCF20 ZNF217 ZHX2 CASZ1 PRDM2 SALL1 ZNF608 BAHCC1 | 2.76e-06 | 398 | 161 | 11 | 35016035 |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | JCAD CDK18 AMPD2 TCF20 SASH1 NAA10 FAM117B C6orf132 ARFGEF3 STOX2 C2CD3 DCP1B RPTOR DNMBP SRRM2 MACIR | 2.77e-06 | 861 | 161 | 16 | 36931259 |
| Pubmed | Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability. | MYO9B RTN3 TACC2 ZNF217 UPF3B RIMBP3 ARFGEF3 SALL1 RPTOR DNMBP ZMYM3 PRRC2B PPP6R3 | 3.94e-06 | 588 | 161 | 13 | 38580884 |
| Pubmed | Proteome-scale mapping of binding sites in the unstructured regions of the human proteome. | JCAD TSHZ3 TSPOAP1 PPFIBP2 POM121C MAP3K1 C6orf132 SALL1 HSH2D WNK2 IQCE | 5.76e-06 | 430 | 161 | 11 | 35044719 |
| Pubmed | TSHZ3 RNF31 MYO9B AFF3 CASP4 LAMB3 FAM117B TACC2 UPF3B SNX19 ZNF608 FARS2 RIPOR1 ASCC3 MOCS1 PRRC2B PPP6R3 CBX2 | 1.47e-05 | 1215 | 161 | 18 | 15146197 | |
| Pubmed | IL12RB2 RNF31 CHD3 POM121C ZNF512B BPTF PWWP2B BRCA1 ZNF608 RPTOR ASCC3 SRRM2 PHF10 ZMYM3 PRRC2B SPATC1L BAHCC1 | 1.81e-05 | 1116 | 161 | 17 | 31753913 | |
| Pubmed | A genome-wide association study (GWAS) for bronchopulmonary dysplasia. | 1.84e-05 | 34 | 161 | 4 | 23897914 | |
| Pubmed | SOX10 regulates an alternative promoter at the Charcot-Marie-Tooth disease locus MTMR2. | 2.13e-05 | 2 | 161 | 2 | 27466180 | |
| Pubmed | 2.13e-05 | 2 | 161 | 2 | 29898387 | ||
| Pubmed | 2.13e-05 | 2 | 161 | 2 | 11847113 | ||
| Pubmed | 2.13e-05 | 2 | 161 | 2 | 21171965 | ||
| Pubmed | 2.13e-05 | 2 | 161 | 2 | 38102338 | ||
| Pubmed | TACC3 expression is tightly regulated during early differentiation. | 2.13e-05 | 2 | 161 | 2 | 12711550 | |
| Pubmed | A census of human transcription factors: function, expression and evolution. | SOX10 KLF11 TSHZ3 UNCX THAP10 MESP1 ZHX2 PRDM2 HIVEP3 BCL6B SALL1 DMRT3 DLX4 CRAMP1 TBX5 | 2.29e-05 | 908 | 161 | 15 | 19274049 |
| Pubmed | Cep120 and TACCs control interkinetic nuclear migration and the neural progenitor pool. | 2.69e-05 | 13 | 161 | 3 | 17920017 | |
| Pubmed | TSHZ3 TCF20 CHD3 ZNF217 PRDM2 SALL1 ZNF608 TACC3 ASCC3 ZMYM3 | 2.74e-05 | 418 | 161 | 10 | 34709266 | |
| Pubmed | SOX10 KLF11 PCGF2 TCF20 RNF31 TACC2 ZNF217 GTF2IRD1 BRCA1 DLX4 TACC3 PHF10 ZMYM3 | 2.84e-05 | 709 | 161 | 13 | 22988430 | |
| Pubmed | The in vivo Interaction Landscape of Histones H3.1 and H3.3. | TSHZ3 TCF20 INTS1 CHD3 CASZ1 PRDM2 ZNF512B BPTF BRCA1 USP3 ZMYM3 CBX2 | 2.87e-05 | 608 | 161 | 12 | 36089195 |
| Pubmed | The TACC domain identifies a family of centrosomal proteins that can interact with microtubules. | 6.37e-05 | 3 | 161 | 2 | 11121038 | |
| Pubmed | 6.37e-05 | 3 | 161 | 2 | 15226440 | ||
| Pubmed | Negative regulation of BRCA1 by transforming acidic coiled-coil protein 3 (TACC3). | 6.37e-05 | 3 | 161 | 2 | 29355525 | |
| Pubmed | Cooperative Mesp activity is required for normal somitogenesis along the anterior-posterior axis. | 6.37e-05 | 3 | 161 | 2 | 16996494 | |
| Pubmed | 6.37e-05 | 3 | 161 | 2 | 30174241 | ||
| Pubmed | Common variants of ZNF750, RPTOR and TRAF3IP2 genes and psoriasis risk. | 6.37e-05 | 3 | 161 | 2 | 24005976 | |
| Pubmed | 6.37e-05 | 3 | 161 | 2 | 20809358 | ||
| Pubmed | RANKL and RANK: From Mammalian Physiology to Cancer Treatment. | 6.37e-05 | 3 | 161 | 2 | 29241686 | |
| Pubmed | 7.55e-05 | 18 | 161 | 3 | 12493763 | ||
| Pubmed | 8.25e-05 | 153 | 161 | 6 | 10718198 | ||
| Pubmed | 1.21e-04 | 103 | 161 | 5 | 32744500 | ||
| Pubmed | Mutual regulation of conventional protein kinase C and a ubiquitin ligase complex. | 1.27e-04 | 4 | 161 | 2 | 17069764 | |
| Pubmed | 1.27e-04 | 4 | 161 | 2 | 10366448 | ||
| Pubmed | 1.27e-04 | 4 | 161 | 2 | 25053281 | ||
| Pubmed | 1.27e-04 | 4 | 161 | 2 | 15207008 | ||
| Pubmed | RANK ligand as a potential target for breast cancer prevention in BRCA1-mutation carriers. | 1.27e-04 | 4 | 161 | 2 | 27322743 | |
| Pubmed | AMPD2 NAA10 TACC2 PRKD3 DCP1B CDK13 RPTOR TACC3 SRRM2 PPP6R3 | 1.27e-04 | 503 | 161 | 10 | 16964243 | |
| Pubmed | TCF20 UNCX NAA10 CHD3 ZNF217 UPF3B HMMR PRDM2 BPTF BRCA1 CDK13 ASXL2 SRRM2 ZMYM3 PRRC2B | 1.99e-04 | 1103 | 161 | 15 | 34189442 | |
| Pubmed | Shifted Transversal Design smart-pooling for high coverage interactome mapping. | 2.00e-04 | 62 | 161 | 4 | 19447967 | |
| Pubmed | Enhanced self-renewal of hematopoietic stem cells mediated by the polycomb gene product Bmi-1. | 2.11e-04 | 5 | 161 | 2 | 15589172 | |
| Pubmed | 2.11e-04 | 5 | 161 | 2 | 18355772 | ||
| Pubmed | 2.11e-04 | 5 | 161 | 2 | 22110403 | ||
| Pubmed | The Role of N-α-acetyltransferase 10 Protein in DNA Methylation and Genomic Imprinting. | 2.11e-04 | 5 | 161 | 2 | 28943313 | |
| Pubmed | 2.11e-04 | 5 | 161 | 2 | 25646474 | ||
| Pubmed | 2.11e-04 | 5 | 161 | 2 | 15677726 | ||
| Pubmed | 2.11e-04 | 5 | 161 | 2 | 27241552 | ||
| Pubmed | Large-scale targeted sequencing identifies risk genes for neurodevelopmental disorders. | 2.11e-04 | 5 | 161 | 2 | 33004838 | |
| Pubmed | 2.12e-04 | 116 | 161 | 5 | 30804394 | ||
| Pubmed | 2.27e-04 | 347 | 161 | 8 | 15231747 | ||
| Pubmed | 2.37e-04 | 263 | 161 | 7 | 34702444 | ||
| Pubmed | Transcriptional maps of 10 human chromosomes at 5-nucleotide resolution. | 2.55e-04 | 66 | 161 | 4 | 15790807 | |
| Pubmed | SCML2 establishes the male germline epigenome through regulation of histone H2A ubiquitination. | 2.62e-04 | 27 | 161 | 3 | 25703348 | |
| Pubmed | 2.65e-04 | 268 | 161 | 7 | 33640491 | ||
| Pubmed | DNMT3L promotes quiescence in postnatal spermatogonial progenitor cells. | 2.93e-04 | 28 | 161 | 3 | 24850856 | |
| Pubmed | Roles of MIWI, MILI and PLD6 in small RNA regulation in mouse growing oocytes. | 3.16e-04 | 6 | 161 | 2 | 28115634 | |
| Pubmed | A20 controls RANK-dependent osteoclast formation and bone physiology. | 3.16e-04 | 6 | 161 | 2 | 36194667 | |
| Pubmed | Breast cancer susceptibility variants alter risks in familial disease. | 3.16e-04 | 6 | 161 | 2 | 19617217 | |
| Pubmed | 3.16e-04 | 6 | 161 | 2 | 25830658 | ||
| Pubmed | 3.16e-04 | 6 | 161 | 2 | 17359303 | ||
| Pubmed | 3.16e-04 | 6 | 161 | 2 | 12826667 | ||
| Pubmed | SAM domain polymerization links subnuclear clustering of PRC1 to gene silencing. | 3.16e-04 | 6 | 161 | 2 | 24091011 | |
| Pubmed | Direct reprogramming of fibroblasts into functional cardiomyocytes by defined factors. | 3.16e-04 | 6 | 161 | 2 | 20691899 | |
| Pubmed | Duplications of hox gene clusters and the emergence of vertebrates. | 3.16e-04 | 6 | 161 | 2 | 23501471 | |
| Pubmed | BNC2 KLF11 TCF20 CHD3 HIVEP3 BPTF ZNF750 SALL1 BTBD7 PHF10 CBX2 TBX5 | 4.05e-04 | 808 | 161 | 12 | 20412781 | |
| Pubmed | 4.40e-04 | 7 | 161 | 2 | 15964995 | ||
| Pubmed | 4.40e-04 | 7 | 161 | 2 | 23704920 | ||
| Pubmed | 4.40e-04 | 7 | 161 | 2 | 26469858 | ||
| Pubmed | Control of biochemical reactions through supramolecular RING domain self-assembly. | 4.40e-04 | 7 | 161 | 2 | 12438698 | |
| Pubmed | Topology and enzymatic properties of a canonical Polycomb repressive complex 1 isoform. | 4.40e-04 | 7 | 161 | 2 | 31093962 | |
| Pubmed | 4.40e-04 | 7 | 161 | 2 | 12417715 | ||
| Pubmed | The transforming acidic coiled coil proteins interact with nuclear histone acetyltransferases. | 4.40e-04 | 7 | 161 | 2 | 14767476 | |
| Pubmed | 4.40e-04 | 7 | 161 | 2 | 21402785 | ||
| Pubmed | The STUbL RNF4 regulates protein group SUMOylation by targeting the SUMO conjugation machinery. | FLNC TCF20 INTS1 RTN3 LAMB3 SMPD4 FNDC3A CASZ1 ZNF707 ZNF608 RPTOR SRRM2 USP3 ZMYM3 PPP6R3 | 4.97e-04 | 1203 | 161 | 15 | 29180619 |
| Pubmed | Efficient isolation of novel mouse genes differentially expressed in early postimplantation embryos. | 5.24e-04 | 34 | 161 | 3 | 7490078 | |
| Pubmed | 5.24e-04 | 34 | 161 | 3 | 23342106 | ||
| Pubmed | Docking motif-guided mapping of the interactome of protein phosphatase-1. | 5.32e-04 | 80 | 161 | 4 | 19389623 | |
| Pubmed | 5.43e-04 | 217 | 161 | 6 | 34048709 | ||
| Pubmed | 5.72e-04 | 35 | 161 | 3 | 11013070 | ||
| Pubmed | 5.86e-04 | 8 | 161 | 2 | 15143159 | ||
| Pubmed | 5.86e-04 | 8 | 161 | 2 | 15469977 | ||
| Pubmed | Loss of Cited2 causes congenital heart disease by perturbing left-right patterning of the body axis. | 5.86e-04 | 8 | 161 | 2 | 21224256 | |
| Pubmed | Neuropilin receptors guide distinct phases of sensory and motor neuronal segmentation. | 5.86e-04 | 8 | 161 | 2 | 19403658 | |
| Pubmed | 5.86e-04 | 8 | 161 | 2 | 14602875 | ||
| Pubmed | BRACHYURY directs histone acetylation to target loci during mesoderm development. | 5.86e-04 | 8 | 161 | 2 | 29141987 | |
| Pubmed | Glycogen synthase kinase-3: properties, functions, and regulation. | 5.86e-04 | 8 | 161 | 2 | 11749387 | |
| Pubmed | Guidance of trunk neural crest migration requires neuropilin 2/semaphorin 3F signaling. | 5.86e-04 | 8 | 161 | 2 | 16319111 | |
| Pubmed | Influence of mesodermal Fgf8 on the differentiation of neural crest-derived postganglionic neurons. | 5.86e-04 | 8 | 161 | 2 | 22040872 | |
| Pubmed | 5.86e-04 | 8 | 161 | 2 | 24742196 | ||
| Pubmed | Early patterning and specification of cardiac progenitors in gastrulating mesoderm. | 5.86e-04 | 8 | 161 | 2 | 25296024 | |
| Interaction | TOP3B interactions | SEMA4F FLNC HIP1 MYO9B MEX3D INTS1 ADGRB2 LAMB3 GTF2IRD1 POM121C BAHD1 C2CD2 CASZ1 C6orf132 PPP1R26 HIVEP3 GAS2L1 C2CD3 PWWP2B CDK13 BTBD7 RPTOR DISP2 RIPOR1 CACNA1H DNMBP ADAMTSL4 CRAMP1 WNK2 PRRC2B IQCE CBX2 BAHCC1 | 2.25e-08 | 1470 | 156 | 33 | int:TOP3B |
| Interaction | FEV interactions | TCF20 ZNF217 ZHX2 ZNF512B SALL1 ZNF608 ASXL2 PHF10 ZMYM3 PRRC2B CBX2 | 5.38e-07 | 203 | 156 | 11 | int:FEV |
| Interaction | CRX interactions | SOX10 TCF20 ZNF217 ZHX2 ZNF512B SALL1 ZNF608 ASXL2 PHF10 ZMYM3 PRRC2B BAHCC1 | 7.00e-07 | 254 | 156 | 12 | int:CRX |
| Interaction | TEAD1 interactions | 1.17e-06 | 176 | 156 | 10 | int:TEAD1 | |
| Interaction | PAX6 interactions | SOX10 TSHZ3 DSCAM CHD3 ZHX2 ZNF512B BPTF SALL1 ZNF608 ASXL2 PHF10 ZMYM3 PRRC2B | 5.68e-06 | 366 | 156 | 13 | int:PAX6 |
| Interaction | MDFI interactions | DBF4B LAMB3 BAHD1 ZNF707 ZNF512B BCL6B DMRT3 FARS2 ZNF648 ETNK2 CCDC120 FAM124B MACIR CBX2 | 6.65e-06 | 430 | 156 | 14 | int:MDFI |
| Interaction | YWHAE interactions | JCAD CDK18 AMPD2 SASH1 RNF31 PPFIBP2 FAM117B TACC2 SHROOM2 MAP3K1 C6orf132 ZNF750 STOX2 BRCA1 DCP1B CDK13 RPTOR MTMR2 MAST1 PRKCB ASXL2 DNMBP SRRM2 MACIR WNK2 | 1.23e-05 | 1256 | 156 | 25 | int:YWHAE |
| Interaction | SP7 interactions | TSHZ3 TCF20 CHD3 ZNF217 BRCA1 ZNF608 DLX4 FAM124B PHF10 PRRC2B PPP6R3 | 2.57e-05 | 304 | 156 | 11 | int:SP7 |
| Interaction | RBBP4 interactions | TSHZ3 TCF20 CHD3 ZHX2 ZNF512B BPTF PWWP2B SALL1 BRCA1 RPTOR ASXL2 ASCC3 SRRM2 ZMYM3 BAHCC1 | 4.02e-05 | 573 | 156 | 15 | int:RBBP4 |
| Interaction | CBX3 interactions | KLF11 PCGF2 TCF20 CHD3 ZNF217 GTF2IRD1 BAHD1 ZNF512B ZNF750 BRCA1 ASXL2 SRRM2 PHF10 ADAMTSL4 ZMYM3 PRRC2B | 4.28e-05 | 646 | 156 | 16 | int:CBX3 |
| Interaction | MID2 interactions | CDK18 BAHD1 BCL6B DMRT3 BRCA1 FARS2 ZNF648 ETNK2 CCDC120 ADAMTSL4 | 4.53e-05 | 267 | 156 | 10 | int:MID2 |
| Interaction | KRTAP10-3 interactions | NAA10 THAP10 BAHD1 BCL6B DMRT3 FARS2 DDX43 FAM124B ADAMTSL4 CBX2 | 1.01e-04 | 294 | 156 | 10 | int:KRTAP10-3 |
| Interaction | ZNF202 interactions | 1.05e-04 | 32 | 156 | 4 | int:ZNF202 | |
| Cytoband | 17q25.3 | 3.01e-05 | 101 | 161 | 5 | 17q25.3 | |
| Cytoband | 7p22.3 | 2.34e-04 | 34 | 161 | 3 | 7p22.3 | |
| GeneFamily | Zinc fingers C2H2-type|ZF class homeoboxes and pseudogenes | BNC2 KLF11 TSHZ3 KLF14 ZNF217 ZHX2 CASZ1 ZNF707 HIVEP3 BCL6B SALL1 ZNF608 ZNF648 | 1.79e-04 | 718 | 101 | 13 | 28 |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C1_SMG_CELL | SOX10 KLF11 PPFIBP2 STXBP5 ANO1 CASP4 TACC2 ZNF217 MESP1 NACAD SNX19 CASZ1 HIVEP3 ZNF750 ITPKC AJM1 HSH2D ARHGEF3 WNK2 IQCE | 6.72e-08 | 775 | 161 | 20 | M45713 |
| Coexpression | BENPORATH_SUZ12_TARGETS | SOX10 SEMA4F HTR1A CHRDL2 ADGRB2 KLF14 TNFRSF11A MESP1 ABCC6 CASZ1 RIMBP3 DMRT3 ACAN SLC6A5 RIPOR1 RIMBP3C DLX4 RIMBP3B USP3 TBX5 | 5.97e-06 | 1035 | 161 | 20 | M9898 |
| Coexpression | ASTON_MAJOR_DEPRESSIVE_DISORDER_DN | 6.89e-06 | 160 | 161 | 8 | M11011 | |
| ToppCell | RSV-Healthy-6|Healthy / Virus stimulation, Condition and Cluster | 1.54e-07 | 164 | 161 | 8 | 1b9c5a6dc4e09b90f92e98b81a5ee620f8479cc7 | |
| ToppCell | RSV-Healthy-6|RSV / Virus stimulation, Condition and Cluster | 1.54e-07 | 164 | 161 | 8 | ab312b8c2f828ea7331f2a340c4df81587a23b5c | |
| ToppCell | Smart-seq2-lymph_node_(Smart-seq2)-lymphocytic-B_lymphocytic-B_cell|lymph_node_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 5.53e-07 | 194 | 161 | 8 | ff661419b697aef51a53fdeac8d37d870d65f491 | |
| ToppCell | CD8+_Memory_T_cell-RSV-6|CD8+_Memory_T_cell / cell class, Virus stimulation and cluster | 1.79e-06 | 158 | 161 | 7 | 5ae737757a49fc96bde1e57e02066f9f65654ea1 | |
| ToppCell | facs-Skin-Skin_Anagen-18m-Epithelial-epidermal_cell|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.26e-06 | 173 | 161 | 7 | 0f9c1d3298e59e6d22bb3306f0f445f490be8bbd | |
| ToppCell | ASK440-Epithelial-Transformed_epithelium|Epithelial / Donor, Lineage and Cell class of Lung cells from Dropseq | 3.94e-06 | 178 | 161 | 7 | 86f1741636ed3e85bb4a65f84949b718fc38c290 | |
| ToppCell | droplet-Lung-LUNG-1m-Epithelial-Club_Cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.26e-06 | 186 | 161 | 7 | e52cf44989c57c433bf82e9fa13b4643e88f3577 | |
| ToppCell | droplet-Lung-LUNG-1m-Epithelial-club_cell_of_bronchiole|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.26e-06 | 186 | 161 | 7 | 4c0b59d845b79323e7a3287e7c4d249f5f322556 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_B-B_cell|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 7.16e-06 | 195 | 161 | 7 | 481989d2e5bd2582da3d86b0155c4d6615317067 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_B|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 7.16e-06 | 195 | 161 | 7 | 6108a27523d1b93a7fbe35cb95704a5ad9071e3c | |
| ToppCell | COVID-19-kidney-TAL|kidney / Disease (COVID-19 only), tissue and cell type | 7.40e-06 | 196 | 161 | 7 | 04f5eb206ed3016a737609a3ebac0c1fcabb94ef | |
| ToppCell | Bronchial-NucSeq-Epithelial-Epi_submucosal-gland|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 8.45e-06 | 200 | 161 | 7 | 85c0f038bcfb42669dca2b80273b0f8a1421405e | |
| ToppCell | TCGA-Brain-Primary_Tumor-Low_Grade_Glioma-Oligodendroglioma-5|TCGA-Brain / Sample_Type by Project: Shred V9 | 1.07e-05 | 137 | 161 | 6 | a7c76201b8901b2ef7ebbb4dfe0cec0dc4534ef5 | |
| ToppCell | remission-unassigned|remission / disease stage, cell group and cell class | 2.07e-05 | 154 | 161 | 6 | 4130769829b838cc8a075c87ff6c187f0f507f8b | |
| ToppCell | remission-unassigned|World / disease stage, cell group and cell class | 2.15e-05 | 155 | 161 | 6 | d81bec894381e3e2d6249a567e8108b8423e5c54 | |
| ToppCell | facs-Marrow-KLS-18m-Myeloid-CD4+_macrophage|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.31e-05 | 157 | 161 | 6 | 5d08ff0ba9d3df9cc30f13cab2d2b395ea6f3446 | |
| ToppCell | facs-Marrow-KLS-18m-Myeloid-macrophage|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.31e-05 | 157 | 161 | 6 | ad9c9b7dfeee3ae46e7e593c51a0407df12195b4 | |
| ToppCell | TCGA-Brain-Primary_Tumor-Low_Grade_Glioma-Oligodendroglioma|TCGA-Brain / Sample_Type by Project: Shred V9 | 2.66e-05 | 161 | 161 | 6 | 5f6b2d7f80a8ee16651e304481d2da3fae313824 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d02_child-Lymphocytic-Lymphocytic_B|Mild-Moderate_progression_d02_child / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.86e-05 | 163 | 161 | 6 | 6bed27d2f67a430a847da5eb47878d14b4949c45 | |
| ToppCell | E18.5-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_ILC-NK-NK-NK_G2M|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.06e-05 | 165 | 161 | 6 | ec16a4979b3f203c9f66ed387a7a17bf3a1d3f86 | |
| ToppCell | PND07-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_ILC-NK-ILC-ILC_G2M|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.38e-05 | 168 | 161 | 6 | a7eb28e15b591997f1aee09501cb20ae18beca08 | |
| ToppCell | facs-Lung-3m-Hematologic-lymphocytic-CD4-positive,_alpha-beta_T_cell-CD4-positive,_alpha-beta_T_cell_l21|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.74e-05 | 171 | 161 | 6 | f1fdc0ec3399ed6955976d02be7e5fc329a64276 | |
| ToppCell | 3'-Child04-06-SmallIntestine-Endothelial-lymphatic_endothelial-LEC1_(ACKR4+)|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.99e-05 | 173 | 161 | 6 | 85083b9ce20351dd69aa2327ad087b848b4307ff | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Endothelial-blood_vessel_EC-Mature_venous_EC|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.67e-05 | 178 | 161 | 6 | ea10117026021c959ffc871fc377cdb3e161d264 | |
| ToppCell | CTRL-Myeloid-cDC|Myeloid / Disease state, Lineage and Cell class | 5.29e-05 | 182 | 161 | 6 | ee137574b8f0e684a4a7cb26226877c471cae433 | |
| ToppCell | IPF-Lymphoid-B|IPF / Disease state, Lineage and Cell class | 5.45e-05 | 183 | 161 | 6 | e37d2c015c34471a8a54a0299e94b0371e1ada5a | |
| ToppCell | Primary_Visual_cortex_(V1C)-Non-neuronal-Macroglial-Oligo|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.62e-05 | 184 | 161 | 6 | a2191dd5546efd357b23e625beb3c5820476f243 | |
| ToppCell | droplet-Lung-nan-21m-Epithelial-club_cell_of_bronchiole|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.62e-05 | 184 | 161 | 6 | 7cc3b9bba1f600b40b02fe2456b5d007dbf9fa37 | |
| ToppCell | droplet-Lung-nan-21m-Epithelial-Club_Cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.62e-05 | 184 | 161 | 6 | 53b71c4ac86dc5e42763b8f64fbc917177531017 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Non-neuronal|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.79e-05 | 185 | 161 | 6 | b5277190866d9eb5b85eceaa5ba116ea6e6f286b | |
| ToppCell | COVID-19-Epithelial_cells-Airway_club|COVID-19 / group, cell type (main and fine annotations) | 5.79e-05 | 185 | 161 | 6 | cfe6fd73d817e173fe803bc1683c291d9bcb8608 | |
| ToppCell | Adult-Immune-interstitial_macrophage_(C1Q_positive)-D175|Adult / Lineage, Cell type, age group and donor | 5.79e-05 | 185 | 161 | 6 | ab5704b96f1d368911308797d10c7c52766ab134 | |
| ToppCell | 10x3'2.3-week_17-19-Endothelial-stroma-proliferating_EC|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 5.96e-05 | 186 | 161 | 6 | a844d4f79e0ad5d6c60a4488ffd8f4f21b7eed04 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Thick_Ascending_Limb_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 6.14e-05 | 187 | 161 | 6 | 87b3d0478693d4c54ff06b74e5903036b9c1ee6a | |
| ToppCell | Children_(3_yrs)-Mesenchymal-pericyte_cell-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 6.14e-05 | 187 | 161 | 6 | 86250acf088ec0c4800a0dfa031b0d4f7e52c342 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Intermediate_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 6.14e-05 | 187 | 161 | 6 | 42a1267bfc27b4460b8409ada580a87c4385841c | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 6.14e-05 | 187 | 161 | 6 | 64afdea159f5e67a1e5cea35ce898aae6e80aea5 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Non-neuronal-Macroglial|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.14e-05 | 187 | 161 | 6 | 97e520705491c8f52a32025311a9fa7b9176979a | |
| ToppCell | human_hepatoblastoma-Tumor_cells-T2|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 6.14e-05 | 187 | 161 | 6 | f3e37c18ac6471c7992609bbddfa4975571c815c | |
| ToppCell | LA-03._Atrial_Cardiomyocyte|World / Chamber and Cluster_Paper | 6.33e-05 | 188 | 161 | 6 | 6d249fe92d51a19da19ec14bb2262d394255d577 | |
| ToppCell | Somatosensory_Cortex_(S1)-Non-neuronal-Macroglial-Oligo|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.33e-05 | 188 | 161 | 6 | 60242c29c7f16c94a84685d3bc4ed93a66e70152 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 6.33e-05 | 188 | 161 | 6 | b2d68a32314e9b099ed74d974079ad96359d1ae3 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-Myofibroblast|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.33e-05 | 188 | 161 | 6 | 293f2fa99f5f96aa7fd2b2a5cc94ff60eeaabe11 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Non-neuronal-Macroglial-Oligo|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.52e-05 | 189 | 161 | 6 | 70eea8c94fa56bb15bee8065de47acea156794e9 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 6.52e-05 | 189 | 161 | 6 | 127ad2ba3e794df8cce2eee3e4171bccb5aad51b | |
| ToppCell | 10x5'v1-week_12-13-Mesenchymal_fibro-stroma-endosteal_fibroblast|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 6.52e-05 | 189 | 161 | 6 | 473b01c9162b12b90a617c600238436177a0d18d | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 6.52e-05 | 189 | 161 | 6 | 2cfb4d12f75678d1619f4743838a0e954bd57761 | |
| ToppCell | Control-Stromal_mesenchymal-Lung_smooth_muscle|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.52e-05 | 189 | 161 | 6 | 45e588b2a4ad9e3ff74e22d9d627ed3571f3b8b8 | |
| ToppCell | Children_(3_yrs)-Immune-interstitial_macrophage_(C1Q_positive)-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 6.71e-05 | 190 | 161 | 6 | 2d54fca50593fbd11fe13fc2bfaf937a05db776d | |
| ToppCell | COVID-19-lung-AT2|COVID-19 / Disease (COVID-19 only), tissue and cell type | 6.71e-05 | 190 | 161 | 6 | 27a1a86620fe9b5ee930d388b32352206485e6d0 | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2|Children_(3_yrs) / Lineage, Cell type, age group and donor | 6.91e-05 | 191 | 161 | 6 | a0332a4ef629510fb313ec119195c44a3f704a80 | |
| ToppCell | COVID-19-lung-AT2|lung / Disease (COVID-19 only), tissue and cell type | 6.91e-05 | 191 | 161 | 6 | 276455a64c2c3503d5048615762eb2ee37f0ac70 | |
| ToppCell | Children_(3_yrs)-Immune-natural_killer_cell-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 6.91e-05 | 191 | 161 | 6 | 6345c1aa0fd2f9f2154a44f9393bf7c72bb1f44e | |
| ToppCell | Fetal_29-31_weeks-Endothelial-alveolar_capillary_endothelial_cell_(Cap2;_aerocyte)-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 7.11e-05 | 192 | 161 | 6 | 7197e401e563441ab94815f7619e032ebef9e586 | |
| ToppCell | Epithelial-alveolar_epithelial_cell_type_2|World / Lineage, Cell type, age group and donor | 7.11e-05 | 192 | 161 | 6 | 58c3737be7acce39fd2b91d70d6d7b2bbaa4f710 | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 7.11e-05 | 192 | 161 | 6 | cc9911e182a289779a2612bc213daae5607689e7 | |
| ToppCell | droplet-Bladder-nan-3m-Epithelial-nan|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.25e-05 | 119 | 161 | 5 | 018162114bc22a9780fded5887f1f78211851700 | |
| ToppCell | Fibroblasts-CD55+_Fibroblasts|World / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues | 7.31e-05 | 193 | 161 | 6 | 8f4bf9a2fbedae35432dad96730b00c70185874c | |
| ToppCell | PCW_10-12-Endothelial-Endothelial_cycling-endo_proliferating1_(10)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 7.31e-05 | 193 | 161 | 6 | 643f992dbce639e7d147924d8b8f455fcebf215a | |
| ToppCell | Adult-Immune-interstitial_macrophage_(C1Q_positive)|Adult / Lineage, Cell type, age group and donor | 7.31e-05 | 193 | 161 | 6 | 31c0978ba78c9516d498aec0798902e57555e557 | |
| ToppCell | Children_(3_yrs)-Immune-natural_killer_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 7.31e-05 | 193 | 161 | 6 | 1cb666375bc4e1b11a146d20896c9b5ae6fd0887 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_B-B_cell-B_c02-MS4A1-CD27|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 7.53e-05 | 194 | 161 | 6 | 5cd72330c9d9bb21b6c9d5d35085eade101486d1 | |
| ToppCell | nucseq-Immune-Immune_Myeloid-pMON-pMON|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 7.53e-05 | 194 | 161 | 6 | e237384b02be460d44eeada3026a5691c66f6fc1 | |
| ToppCell | nucseq-Immune-Immune_Myeloid-pMON|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 7.53e-05 | 194 | 161 | 6 | 0bc83ae79873a5e473e6e1e3111924cd003986a1 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_B-B_cell-B_c02-MS4A1-CD27|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 7.53e-05 | 194 | 161 | 6 | d852aebf7a763b9a776c4570711f0c759f591910 | |
| ToppCell | COVID-19-lung-Pericytes/_Smooth_Muscle|COVID-19 / Disease (COVID-19 only), tissue and cell type | 7.96e-05 | 196 | 161 | 6 | 754a3613340932563cd8424d775e18b93c3a1aaa | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Glial-Neuronal-Oligodendrocyte-Oligodendrocyte-B|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 8.19e-05 | 197 | 161 | 6 | 82b8e22317cad6d3786bd70d91107007c0ccd7cd | |
| ToppCell | PCW_13-14-Mesenchymal|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 8.19e-05 | 197 | 161 | 6 | 73a2085d2682d636726a5432d572ae2a3fbe1c3f | |
| ToppCell | 10x_5'_v1-Non-neoplastic-Glial-Neuronal-Oligodendrocyte-Oligodendrocyte|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 8.66e-05 | 199 | 161 | 6 | 5d2e85e40b6b52b1809e680b952913d77215b3d0 | |
| ToppCell | 10x_5'_v1-Non-neoplastic-Glial-Neuronal-Oligodendrocyte|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 8.66e-05 | 199 | 161 | 6 | 9dd4b17fb8c70ab9e126b23b72600463f3db832d | |
| ToppCell | Smart-start-Cell-Wel_seq-Neoplastic-Differentiated-like-MES-like-MES-like_hypoxia_independent-F|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 8.66e-05 | 199 | 161 | 6 | 85bb28369e0568b7b3bda095722102fc793f60ef | |
| ToppCell | 10x3'2.3-week_14-16-Endothelial-stroma-tip_EC|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 8.66e-05 | 199 | 161 | 6 | 1c69395c9305b6ecb0a826d46c8e8ec95795ad6d | |
| ToppCell | 10x_5'_v1-Non-neoplastic-Glial-Neuronal-Oligodendrocyte-Oligodendrocyte-Z|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 8.66e-05 | 199 | 161 | 6 | 6fb5f931e6217142de38c1fffc011e63bda4772b | |
| ToppCell | 10x_5'_v1-Non-neoplastic-Glial-Neuronal|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 8.66e-05 | 199 | 161 | 6 | 1bb5797e8e0552bf9b44bf4c958d1aa6dbe6c756 | |
| ToppCell | Tracheal-NucSeq-Stromal-Schwann-Schwann_Myelinating|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 8.66e-05 | 199 | 161 | 6 | 4e4bdcd2e8b518156d5ebd294804180acaa3566b | |
| ToppCell | Bronchial-NucSeq-Epithelial-Epi_submucosal-gland-SMG_Serous|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 8.90e-05 | 200 | 161 | 6 | 030efc36bbb848da31b0db3f74d46aac9c79cc9b | |
| ToppCell | Tracheal-NucSeq-Epithelial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 8.90e-05 | 200 | 161 | 6 | d3af0a706baf66e3f32e67b17dcfc31e5b32ce0e | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Glial-Neuronal-Oligodendrocyte-Oligodendrocyte|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 8.90e-05 | 200 | 161 | 6 | 0bfd41c12887479ceb62c3db0a3c3ba5007eb62b | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Glial-Neuronal-Oligodendrocyte|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 8.90e-05 | 200 | 161 | 6 | 159377d904394d91e09913131e9a93e08189955a | |
| ToppCell | LPS_IL1RA_TNF-Endothelial-Endothelial-Gen_Cap|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 8.90e-05 | 200 | 161 | 6 | b2d4e6f3e8e4da62e6b02758ab2ed8f505269f9a | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_myocytic-Myofibroblastic-Myofibroblast|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 8.90e-05 | 200 | 161 | 6 | dcdaec3ca3a3024dc1b8788c417003f84c2bffdc | |
| ToppCell | Tracheal-10x5prime-Epithelial-Epi_submucosal-gland|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 8.90e-05 | 200 | 161 | 6 | a3e044468de437948b63c517e0a4773cc247c906 | |
| ToppCell | Tracheal-NucSeq-Epithelial-Epi_submucosal-gland|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 8.90e-05 | 200 | 161 | 6 | 0eb9ad8c0373bcc62029ec21c590ed03aaacd039 | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-2M-Stem_cells-neuroepithelial-like_cells|Organoid-2M / Sample Type, Dataset, Time_group, and Cell type. | 9.86e-05 | 127 | 161 | 5 | 9071cd0953c8bb6746dc9cd13d153e3d6ef40b08 | |
| ToppCell | Smart-seq2-spleen_(Smart-seq2)-myeloid-myeloid_dendritic-plasmacytoid_dendritic_cell|spleen_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.41e-04 | 137 | 161 | 5 | 3f4746fb6fc36c90a8cd25725531a1503422cfbf | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.66e-04 | 142 | 161 | 5 | 5b6b0c611c83b23ef7289854a515b78f6cf84500 | |
| ToppCell | Severe-B_naive-8|World / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 1.83e-04 | 145 | 161 | 5 | a24cad86509208bc7267b02ef1d1b0a25a2a7043 | |
| ToppCell | facs-Marrow-T-cells-3m-Myeloid-granulocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.02e-04 | 148 | 161 | 5 | b4632029ebd14969bda59a1bd1454eadb8efe563 | |
| ToppCell | facs-Marrow-T-cells-3m-Myeloid-granulocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.02e-04 | 148 | 161 | 5 | ba277c898678dd36f8dc1d681301c71901b89055 | |
| ToppCell | droplet-Lung-18m-Hematologic-lymphocytic-CD8-positive,_alpha-beta_T_cell-CD8-positive,_alpha-beta_T_cell_l21|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.08e-04 | 149 | 161 | 5 | 65778f19599b4955c0a16f0121237656449431fb | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum_-18m-Neuronal-neuron|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.12e-04 | 81 | 161 | 4 | 1a22222f2b4ab30f7aa31820029c267a0f2190ec | |
| ToppCell | mild_COVID-19_(asymptomatic)-NK_CD56bright|World / disease group, cell group and cell class (v2) | 2.35e-04 | 153 | 161 | 5 | aff5c8ab1fb4ebc324cec02cf562b7484bb10db8 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-airway_smooth_muscle_cell-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.50e-04 | 155 | 161 | 5 | cd7d95cbcad248670e531d80bb83c55e36ebc573 | |
| ToppCell | 367C-Myeloid-Macrophage-SPP1+_Macrophage_3|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 2.58e-04 | 156 | 161 | 5 | fc8b8aef29d6d1c0f0c1d08280d8aaff8d30535e | |
| ToppCell | Children_(3_yrs)-Mesenchymal-chondrocyte-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.58e-04 | 156 | 161 | 5 | 60f1ce38e34b582f589db1e0d6139282c1902b2b | |
| ToppCell | 3'_v3-bone_marrow-Lymphocytic_B-Pro-B|bone_marrow / Manually curated celltypes from each tissue | 2.58e-04 | 156 | 161 | 5 | b093dbba6662e4fffc8aa577587b77f64ac44b56 | |
| ToppCell | droplet-Lung-nan-3m-Lymphocytic-Proliferating_NK|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.73e-04 | 158 | 161 | 5 | ee8ce3cd202807df692b28bb1a81827d49d73862 | |
| ToppCell | 368C-Myeloid-Dendritic-cDC_activated|368C / Donor, Lineage, Cell class and subclass (all cells) | 2.89e-04 | 160 | 161 | 5 | bcd90ef96464bd901b87b94c696de70c113bfd03 | |
| ToppCell | droplet-Lung-18m-Hematologic-lymphocytic-mature_NK_T_cell-mature_NK_T_cell_l44|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.89e-04 | 160 | 161 | 5 | 6b0faaa371650563f585722f5b2fb319e124ec38 | |
| ToppCell | 10x5'-Liver-Lymphocytic_Invariant-Inducer-like-ILC3|Liver / Manually curated celltypes from each tissue | 3.15e-04 | 163 | 161 | 5 | 7f61483eeb1fde21843c6391468e13cb0cc2a89f | |
| Drug | Pilocarpine nitrate [148-72-1]; Up 200; 14.8uM; MCF7; HT_HG-U133A | HIP1 PCGF2 RNF31 CEP164 SLC4A2 ZNF512B ZNF750 ETNK2 PRRC2B BAHCC1 | 1.25e-06 | 196 | 159 | 10 | 5341_UP |
| Drug | cox-2 inhibitor I; Up 200; 10uM; MCF7; HG-U133A | 1.01e-05 | 196 | 159 | 9 | 253_UP | |
| Drug | Pseudopelletierine hydrochloride [6164-62-1]; Up 200; 21uM; MCF7; HT_HG-U133A | 1.05e-05 | 197 | 159 | 9 | 2766_UP | |
| Drug | Tropine [120-29-6]; Down 200; 28.4uM; MCF7; HT_HG-U133A | 1.10e-05 | 198 | 159 | 9 | 3569_DN | |
| Drug | Medrysone [2668-66-8]; Down 200; 11.6uM; MCF7; HT_HG-U133A | 1.14e-05 | 199 | 159 | 9 | 3403_DN | |
| Disease | aspartate aminotransferase measurement, serum alanine aminotransferase measurement, low density lipoprotein triglyceride measurement, body fat percentage, high density lipoprotein cholesterol measurement, sex hormone-binding globulin measurement | BNC2 HTR1A KLF14 POM121C SNX19 HIVEP3 BPTF ACAN RPTOR PKHD1 UNC79 | 3.39e-06 | 364 | 153 | 11 | EFO_0004612, EFO_0004696, EFO_0004735, EFO_0004736, EFO_0007800, EFO_0009946 |
| Disease | body fat percentage | BNC2 HTR1A KLF14 POM121C SNX19 HIVEP3 BPTF ACAN RPTOR PKHD1 UNC79 PRRC2B | 9.83e-06 | 488 | 153 | 12 | EFO_0007800 |
| Disease | mean arterial pressure | TCF20 MYO9B STXBP5 POM121C CASZ1 PRKD3 HIVEP3 RPTOR PKHD1 NANOS3 ARHGEF3 BAHCC1 | 1.23e-05 | 499 | 153 | 12 | EFO_0006340 |
| Disease | Apnea | 7.99e-05 | 3 | 153 | 2 | C0003578 | |
| Disease | body surface area | LRRC66 BNC2 UNCX MYO9B ACSS2 ZHX2 ZNF608 ACAN RPTOR PKHD1 UNC79 PPP6R3 | 1.40e-04 | 643 | 153 | 12 | EFO_0022196 |
| Disease | visceral adipose tissue measurement | BNC2 HTR1A ADGRB2 POM121C HIVEP3 BPTF RPTOR PKHD1 ARHGEF3 UNC79 | 2.17e-04 | 481 | 153 | 10 | EFO_0004765 |
| Disease | Choledochal Cyst, Type I | 2.64e-04 | 5 | 153 | 2 | C0009439 | |
| Disease | primary hyperaldosteronism (is_implicated_in) | 2.64e-04 | 5 | 153 | 2 | DOID:446 (is_implicated_in) | |
| Disease | Choledochal Cyst, Type II | 2.64e-04 | 5 | 153 | 2 | C1257796 | |
| Disease | Choledochal Cyst, Type III | 2.64e-04 | 5 | 153 | 2 | C1257797 | |
| Disease | Choledochal Cyst, Type IV | 2.64e-04 | 5 | 153 | 2 | C1257798 | |
| Disease | Choledochal Cyst, Type V | 2.64e-04 | 5 | 153 | 2 | C1257799 | |
| Disease | procollagen-lysine,2-oxoglutarate 5-dioxygenase 2 measurement | 2.64e-04 | 5 | 153 | 2 | EFO_0802912 | |
| Disease | Choledochal Cyst | 2.64e-04 | 5 | 153 | 2 | C0008340 | |
| Disease | Pure gonadal dysgenesis 46,XY | 3.95e-04 | 6 | 153 | 2 | cv:C2936694 | |
| Disease | Idiopathic generalized epilepsy | 3.95e-04 | 6 | 153 | 2 | cv:C0270850 | |
| Disease | Prostate cancer, familial | 4.62e-04 | 69 | 153 | 4 | C2931456 | |
| Disease | Swyer Syndrome | 5.51e-04 | 7 | 153 | 2 | C2936694 | |
| Disease | alcohol use disorder (implicated_via_orthology) | 5.57e-04 | 195 | 153 | 6 | DOID:1574 (implicated_via_orthology) | |
| Disease | Abnormality of the skeletal system | 7.33e-04 | 8 | 153 | 2 | C4021790 | |
| Disease | Gonadal Dysgenesis, 46,XY | 7.33e-04 | 8 | 153 | 2 | C0018054 | |
| Disease | hematocrit | JCAD UNCX AFF3 CHD3 ABCC6 CEP164 SLC4A2 SALL1 DGKK PKHD1 ASXL2 ARHGEF3 BAHCC1 TBX5 | 8.18e-04 | 1011 | 153 | 14 | EFO_0004348 |
| Disease | forced expiratory volume | JCAD BNC2 TSHZ3 DSCAM TCP11 AFF3 ZHX2 CASZ1 MAP3K1 ACAN USP3 PRRC2B | 8.74e-04 | 789 | 153 | 12 | EFO_0004314 |
| Disease | Autosomal Recessive Polycystic Kidney Disease | 9.39e-04 | 9 | 153 | 2 | C0085548 | |
| Disease | age at menarche | 1.11e-03 | 594 | 153 | 10 | EFO_0004703 | |
| Disease | bone morphogenetic protein 7 measurement | 1.17e-03 | 10 | 153 | 2 | EFO_0020187 | |
| Disease | cognitive function measurement | HTR1A TCF20 DSCAM DBF4B AFF3 PRR16 STOX2 CLCN2 ZNF608 MTMR2 PKHD1 MAST1 CACNA1H ASXL2 FHDC1 MACIR WNK2 | 1.28e-03 | 1434 | 153 | 17 | EFO_0008354 |
| Disease | 46,XY partial gonadal dysgenesis | 1.42e-03 | 11 | 153 | 2 | C4510744 | |
| Disease | autosomal recessive polycystic kidney disease (biomarker_via_orthology) | 1.42e-03 | 11 | 153 | 2 | DOID:0110861 (biomarker_via_orthology) | |
| Disease | S-warfarin to R-warfarin ratio measurement | 1.53e-03 | 95 | 153 | 4 | EFO_0803331 | |
| Disease | age-related hearing impairment | 1.56e-03 | 324 | 153 | 7 | EFO_0005782 | |
| Disease | bronchopulmonary dysplasia | 1.65e-03 | 45 | 153 | 3 | MONDO_0019091 | |
| Disease | motor neuron disease (implicated_via_orthology) | 1.70e-03 | 12 | 153 | 2 | DOID:231 (implicated_via_orthology) | |
| Disease | sexual dimorphism measurement | LRRC66 MYO9B TCP11 KLF14 ACSS2 GTF2IRD1 CEP164 BPTF ZNF608 ACAN ASXL2 TACC3 SPOCD1 PPP6R3 | 1.90e-03 | 1106 | 153 | 14 | EFO_0021796 |
| Disease | rheumatoid arthritis, anti-citrullinated protein antibody seropositivity, rheumatoid factor seropositivity measurement | 1.97e-03 | 170 | 153 | 5 | EFO_0000685, EFO_0007791, EFO_0007837 | |
| Disease | myopathy (implicated_via_orthology) | 1.99e-03 | 48 | 153 | 3 | DOID:423 (implicated_via_orthology) | |
| Disease | red blood cell density measurement | KLF11 UNCX AFF3 ZNF217 ABCC6 CASZ1 PRKD3 SALL1 PKHD1 ARHGEF3 USP3 MACIR | 2.19e-03 | 880 | 153 | 12 | EFO_0007978 |
| Disease | cognitive function measurement, self reported educational attainment | 2.61e-03 | 355 | 153 | 7 | EFO_0004784, EFO_0008354 | |
| Disease | Antihypertensive use measurement | 2.67e-03 | 265 | 153 | 6 | EFO_0009927 | |
| Disease | rheumatoid arthritis | 2.92e-03 | 462 | 153 | 8 | EFO_0000685 | |
| Disease | attention deficit hyperactivity disorder, substance abuse, antisocial behaviour measurement | JCAD BNC2 TSHZ3 TCF20 AFF3 ADGRB2 TACC2 BPTF ASCC3 UNC79 PRRC2B | 3.15e-03 | 801 | 153 | 11 | EFO_0003888, EFO_0007052, MONDO_0002491 |
| Disease | reticulocyte count | BNC2 MYO9B KLF14 FAM117B ZNF217 ZHX2 MAP3K1 MAST1 ASXL2 FHDC1 ARHGEF3 SPOCD1 USP3 | 3.19e-03 | 1045 | 153 | 13 | EFO_0007986 |
| Disease | Polydactyly | 3.27e-03 | 117 | 153 | 4 | C0152427 | |
| Disease | reticulocyte measurement | BNC2 MYO9B AFF3 KLF14 ZNF217 MAP3K1 MAST1 ASXL2 FHDC1 ARHGEF3 SPOCD1 USP3 MACIR | 3.41e-03 | 1053 | 153 | 13 | EFO_0010700 |
| Disease | ankle injury | 3.59e-03 | 59 | 153 | 3 | EFO_1002021 | |
| Disease | PROSTATE CANCER, HEREDITARY, 1 | 3.77e-03 | 60 | 153 | 3 | C4722327 | |
| Disease | neuroimaging measurement | AFF3 THAP10 TACC2 ZHX2 POM121C MAP3K1 DMRT3 BRCA1 MTMR2 PKHD1 TACC3 WNK2 BAHCC1 | 3.86e-03 | 1069 | 153 | 13 | EFO_0004346 |
| Disease | FEV/FEC ratio | JCAD BNC2 TSHZ3 TCP11 AFF3 ANO1 GTF2IRD1 MAP3K1 HIVEP3 GID4 ACAN RIPOR1 USP3 TBX5 | 4.84e-03 | 1228 | 153 | 14 | EFO_0004713 |
| Disease | Prostatic Neoplasms | 4.98e-03 | 616 | 153 | 9 | C0033578 | |
| Disease | Malignant neoplasm of prostate | 4.98e-03 | 616 | 153 | 9 | C0376358 | |
| Disease | cystatin C measurement | 5.13e-03 | 402 | 153 | 7 | EFO_0004617 | |
| Disease | Global developmental delay | 5.16e-03 | 133 | 153 | 4 | C0557874 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| GAAERSVCTDKPSPG | 1516 | O60241 | |
| SVCTDKPSPGERPSL | 1521 | O60241 | |
| CTSYRGVPASKPEPA | 261 | P51826 | |
| GFPACLPAPKSSTDS | 166 | P58512 | |
| RRPAKGADSFCTPEP | 6 | P04920 | |
| TSGRCAKEAAGPPEP | 316 | Q9P281 | |
| NCSLELPPASGPAKD | 16 | Q9NR81 | |
| APSSPIPRCSGESEQ | 356 | Q6UY14 | |
| VGLSATPAPKSCPER | 16 | P26842 | |
| TALKSPPGVCSRDPT | 61 | P08697 | |
| SPQKFSPEGDLCSSP | 816 | Q6ZN30 | |
| AEGTRCTDPPAGKPA | 6 | Q86V15 | |
| PPESGESTDALKLCP | 96 | P49662 | |
| GRDPPQECSTFSPTD | 51 | Q07002 | |
| PPPDTLASAGDFLCT | 246 | Q96PG8 | |
| ATPGPASKCSPCERS | 21 | C9J069 | |
| ETAPPPLCASRNSKA | 776 | A6QL63 | |
| ASPPPKECDQGTLSA | 1406 | Q6XZF7 | |
| SCVFGAEKSPDDPRP | 26 | Q9NUS5 | |
| GDSTSQSPPIKRSCP | 261 | Q9NR19 | |
| PGPSRCRSDSPAVAA | 36 | Q01433 | |
| PSEGRSPVGCLSETP | 651 | Q12830 | |
| CPLPGRDASKAVFPD | 6 | Q92988 | |
| PKAKAADPPDGFCSS | 1271 | A7MBM2 | |
| ASSSCFSPGPPLEVK | 76 | Q14004 | |
| SCRQEKAPSPTGPAL | 826 | Q76L83 | |
| RGAGKSEPSPSCSPS | 156 | P60323 | |
| ASPKKPGCSSPAAAV | 11 | A6NNM3 | |
| ASPKKPGCSSPAAAV | 11 | A6NJZ7 | |
| GRCTPKSSEPAPATL | 576 | O95153 | |
| THPEGACPSKEPSAD | 206 | Q96DU7 | |
| DSSEEGLPRPRSPCS | 501 | Q6IPM2 | |
| VSVDSEPSCKGGLPR | 836 | Q9C0D6 | |
| LAPGPCPEATSESAT | 61 | Q5KSL6 | |
| ATADAASPFPACKPV | 1566 | Q8N201 | |
| APSCTPAAPQSKDGS | 506 | A6NDA9 | |
| GGPSRAALSPKCSDP | 711 | Q9P266 | |
| ESRGSDPKPENPACP | 771 | Q99665 | |
| LAPSASGPPVCKSSE | 381 | Q96HB5 | |
| EKAAASASCREPPGP | 31 | Q9NVF9 | |
| PGKAEAEKPRCSSTP | 26 | Q96GV9 | |
| SPPSSGEACREEKGL | 186 | P41227 | |
| PFSEKGPPSVCETRS | 976 | Q8IXT1 | |
| PKSPFRVGVTEGCDP | 1336 | Q14315 | |
| RGPESQSCPSKLNPE | 61 | Q6IPT4 | |
| KPPSASSAPALAREC | 586 | Q86XN8 | |
| AVLPAASPCSSPKTG | 21 | O94806 | |
| SCESLGSQPAAARPP | 6 | Q13614 | |
| CPGADKGPASDDPRS | 86 | P05771 | |
| KACPDSLGSPAPSHA | 966 | Q5XXA6 | |
| PGHSEISSTRCPKAP | 321 | Q6WN34 | |
| ATSSCPPKSPLGETR | 186 | Q96JZ2 | |
| GEAAKSPPTICQPDA | 436 | Q8ND30 | |
| PPCSAEVPSDPDKAA | 856 | Q68CR7 | |
| ESPGGAEACTPPRAT | 1361 | Q9Y2H9 | |
| PVTQPCPGESARAAS | 26 | Q9NZB8 | |
| PDKQAPGSDSQPRCV | 451 | Q9NXE4 | |
| PRTPCVGDKDSSPGV | 541 | P16112 | |
| NPCLGADSEKPSSIP | 21 | O00469 | |
| SLPPCPESAGAATTE | 586 | A8CG34 | |
| VRTECPPPAGASAAS | 86 | Q8IVV7 | |
| CESVSDKAPSPATLP | 256 | P35227 | |
| APLKRFNDPSGCAPS | 6 | O75330 | |
| CDSDPATPGAQSPKD | 16 | Q8WUB8 | |
| RLCPPDDSTKSGDSA | 451 | Q9BZI7 | |
| PGVERSSPSKCPSLD | 1491 | P38398 | |
| RAPEPDCPGELKATA | 356 | Q5T0Z8 | |
| DCPGELKATAPASPR | 361 | Q5T0Z8 | |
| STPGAANKCDPSTPA | 361 | Q8IZD4 | |
| KAPPDAAPGLVASNC | 971 | Q711Q0 | |
| ELPEPSGSPTSDRCA | 296 | Q9H5Z6 | |
| PCPQARLPSGDEASS | 221 | Q8N143 | |
| PPTPASKRDCVKGSA | 421 | Q14781 | |
| ASTAQESCPPKPPRA | 246 | Q9Y426 | |
| GEAPLPCDDKLTTSP | 1861 | Q4AC94 | |
| RSAPEKSSGDVPAPC | 281 | P49918 | |
| PKKPEGTCPAAESRT | 206 | Q8NFT6 | |
| PDVAKSKGCFTPESP | 181 | Q9NQL9 | |
| CTSKPATPAPSEKGE | 1551 | Q12873 | |
| DAPGSPLACTEPSRT | 616 | Q99501 | |
| FSEKCDITTAPGPPD | 746 | Q9Y2H6 | |
| SSPEKRSPSAPVCKA | 186 | Q6P1L5 | |
| KEIGDCAPAPGAPST | 1371 | Q5TH69 | |
| PCLEKTPAEGRDSPT | 521 | Q96RY5 | |
| DSQRLGKAGCPPEPS | 6 | Q9H2H0 | |
| AGPTPCAPASFERKN | 311 | P08908 | |
| VARACPQSAKPPSGS | 531 | Q8TBE0 | |
| KSEPCPPGPEVSRDS | 51 | Q9Y264 | |
| KAAPPDCTSTAGLGR | 821 | Q9P203 | |
| EPVPSSPCRAKGTSV | 161 | O14901 | |
| EAPRASSGFSDPIPC | 106 | Q8TD94 | |
| ADRCAPKPGASAGPS | 256 | Q13751 | |
| GEAPTCKSPSCEPKT | 66 | Q3LI83 | |
| PAGSAVPAQSRPCVD | 36 | Q5BLP8 | |
| RPVACPKGDSGESSA | 266 | Q8N8Q3 | |
| DPCKSGSEPKSPEGR | 2016 | Q8NDH2 | |
| KQEAPSCPLAPSDLG | 271 | Q9UHL9 | |
| GDQKPPASLRSSPCA | 1116 | O95180 | |
| SRDRPSCAPSASIPK | 301 | Q6NUJ5 | |
| DCPEGSIPDTPKSAD | 831 | Q9NSC2 | |
| GEKRPIPNPTCTFDD | 231 | Q9NXZ2 | |
| ASKDDSSPPSLGPDC | 441 | Q13029 | |
| PADGTRSPSPCKSLE | 906 | Q13029 | |
| PCLLGAPRKAQDPSS | 1486 | Q5THK1 | |
| SSPAAAEPGEKRAPA | 136 | Q13233 | |
| SGICRFTASPPKPQD | 1866 | O60469 | |
| TLAELPGSPPEKCDS | 446 | O95197 | |
| AVATSPPGAIPKEAC | 246 | Q9Y6A5 | |
| GRSECDSSPEPKALP | 1476 | Q9UQ35 | |
| REESPDKPGSPCASC | 306 | O60522 | |
| ADVSSLCPKEPGERP | 556 | O95754 | |
| SSPCSPPARLGLDQK | 596 | Q8IVB4 | |
| DLPCDSKPESALGAP | 21 | Q99593 | |
| EAERPGVGSCKLSSP | 71 | Q9Y345 | |
| NPCPETGAAFPSKAT | 201 | O95255 | |
| ASPKKPGCSSPAAAV | 11 | Q9UFD9 | |
| EVDKPPCTFSTPSRG | 166 | Q8TC59 | |
| SSCPAEGPPAASKTK | 11 | Q569H4 | |
| PERNCVGSSLPEASP | 31 | P57086 | |
| GATTCLRAPPEPADS | 706 | O00291 | |
| SEEKLSCFPPRVPGD | 261 | Q13796 | |
| RCKPEPAHGSAPTAL | 171 | Q5T8A7 | |
| EGSTKPATPCRPSEA | 316 | Q5T8A7 | |
| VSSPNPGPRDSCTFK | 116 | P08F94 | |
| CADTSAPEPARSLGP | 61 | Q8TC41 | |
| PPSDKDCGRSLVSSP | 26 | Q9BRJ9 | |
| PEDRCKSPTSGSSSP | 706 | Q5T5C0 | |
| DTSPGCAAPSQAPFK | 101 | Q9H0A9 | |
| EGGSLTPVRDSPCTP | 701 | Q8N122 | |
| REQAPSPPAACEKGK | 526 | Q9UPV0 | |
| GKPESCAVTPRFPKS | 2096 | Q8N3C0 | |
| SLFCGSPPPEAASEK | 726 | P51788 | |
| SAPLPSSCGDPEKQR | 466 | Q96EP0 | |
| RESALSAKACTPDGP | 411 | Q6PCB0 | |
| SPCKSPAPEAALGAQ | 136 | Q32MQ0 | |
| SEGRSCKPETSGPPQ | 16 | Q8WWU5 | |
| AAPERTDAKPTAFPC | 136 | Q96C28 | |
| RKASEPCGPPADAIT | 456 | Q5GH72 | |
| SHPKTPADTLPGRCE | 726 | Q9P2F5 | |
| GPTDEAGSECPFPRK | 1201 | Q6ZMY3 | |
| GSEEPRCLSPGSAPS | 16 | P56693 | |
| QKAESRSPSCSPGPA | 2136 | Q5T1R4 | |
| CTSDSKDPSLRPAQP | 246 | Q5JSZ5 | |
| LAPDTSKSCDPPGVT | 791 | O94885 | |
| VKRGSPASPTSPSDC | 1021 | O94885 | |
| LTSPDQPRGPACDAS | 756 | O95359 | |
| GDRVEASTPSCPDPA | 1926 | O95359 | |
| ASTPSCPDPAKDLSR | 1931 | O95359 | |
| SSKDLPSPDSRNCPA | 1316 | Q9UGU0 | |
| GIFSKARDPAPCPAS | 266 | Q92543 | |
| SQENSPSPPRDGCKD | 666 | Q63HK5 | |
| PLCFDPGSPASDKTE | 56 | Q96KM6 | |
| VGSEPAKDCLPAKPS | 751 | Q9Y6X8 | |
| CIAPDSAKFPNGSPS | 11 | Q9Y6I4 | |
| TPPNCAAEDIKASPS | 481 | Q9ULD9 | |
| CRTKADVTPPPDGST | 641 | O75362 | |
| EGTADPVACPRGSSP | 46 | Q5T619 | |
| TRTPGTVEDGSAPCP | 31 | Q9ULZ0 | |
| APCTPAPEAASTRDA | 1491 | Q9Y3S1 | |
| SEAAPGPVSCTRPRA | 121 | Q9P2Z0 | |
| PPAAECATQRAPGSV | 36 | O95363 | |
| KHSDPTLPGTDSLPC | 696 | Q6ZS17 | |
| EAKCAAPRPPSSSPE | 841 | Q5H9R7 | |
| PIPQSGDPADATRCS | 396 | Q14202 | |
| CSTAREEPSSEPGPS | 411 | Q2M3C6 | |
| LPDVCPKEPTGDSHS | 36 | Q9P1Q0 | |
| DAVCSSSLPARKPPN | 191 | Q9Y6Q6 | |
| QPRPGRPADKDAASC | 296 | A6NJT0 | |
| SSKPEELPEFSCGSP | 1726 | Q9P2D8 | |
| SSLDRGCPDAPAPTS | 1161 | O15069 | |
| SKPCGSPRVQEKPDS | 1276 | Q13459 |